Xi'an Giant Biogene Gene Technology Co., Ltd.
A China-based biotechnology enterprise founded in 2000 that positions itself as a global leader in recombinant collagen, focused on bioactive-ingredient skincare, medical devices, and functional foods.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Giant Biogene (Xi'an Giant Biogene Gene Technology Co., Ltd.) is a biotechnology enterprise founded in 2000 that describes itself as a global leader in recombinant collagen and a pioneer and leader in China's professional skin care industry based on bioactive ingredients. Using proprietary synthetic biology technology, it designs, develops and produces bioactive ingredients such as recombinant collagen and rare ginsenosides, focusing on three industry directions: functional skincare products, medical devices, and functional foods and food for special medical purposes. Its brand portfolio includes 可复美 (Comfy), 可丽金 (Collgene), 欣苷 (Skigin) and others. The company states it holds 233 granted and pending patents, and that its recombinant collagen technology obtained the industry's first patent authorization in China, along with a National Technological Invention Award second prize in 2013 and a China Patent Gold Award in 2016. It is listed in Hong Kong under the ticker 02367.HK.
History
Giant Biogene was founded in 2000 and describes itself as a high-tech enterprise rooted in technological aesthetics, and a pioneer and leader in China's professional skin care industry based on bioactive ingredients. It focuses on three industry directions: functional skincare products, medical devices, and functional foods and food for special medical purposes. Its basic research and product development center on its proprietary synthetic biology technology, used to design and develop recombinant collagen, rare ginsenosides and other bioactive ingredients. The company states its recombinant collagen technology obtained the industry's first patent authorization in China, and that it received a National Technological Invention Award second prize in 2013 and a China Patent Gold Award in 2016. It was one of the drafting units of the Chinese pharmaceutical industry standard YY/T 1849-2022 'Recombinant Collagen', which took effect on August 1, 2022. In December 2025 it signed a strategic cooperation agreement with Sweden's Nordberg Medical in Shanghai to jointly advance global development and commercialization of recombinant collagen in medical aesthetics and biomedical fields.
Products and positioning
Global leader in recombinant collagen; pioneer and leader in China's professional skin care industry based on bioactive ingredients.
Comfy (可复美)
A professional care brand providing solutions for skin problems, with recombinant collagen as its core ingredient, focused on scientific skin care research for over ten years.
Collgene (可丽金)
A mid-to-high-end brand under Giant Biogene positioned in the functional skincare field, focused on skin rejuvenation care research, with product effects covering anti-wrinkle, firming, wrinkle-reducing and whitening.
Skigin (欣苷)
A comprehensive anti-aging brand leading ginseng biotechnology, with rare ginsenosides as its core ingredient.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/西安巨子生物基因技术股份有限公司 · Editorial policy · How profiles are compiled